TU Wien: Zell-Stress erhöht die Produktivität

Sorry, this entry is only available in German!

APEPTICO Initiates Phase II Trial with AP301 in Patients with Pulmonary Oedema

Vienna, Austria, June 29, 2012 - APEPTICO, a privately-held biotechnology company developing peptide drugs based on its…

Biomay to present at the Rodman & Renshaw 14th Annual Global Healthcare Conference

Biomay AG announced today that the company has been selected to present at the prestigious 14th Annual Global Healthcre…

Biomay: Innovative Grass Pollen Allergy Vaccine Shows Efficacy in Phase IIA Trial

A novel vaccine for grass pollen allergy has shown significant improvements for patients in a Phase IIa trial. The…

Boehringer Ingelheim BioXcellence: Distinctive brand for the biopharmaceutical contract manufacturing business

Vienna/Austria, 27 June 2012 –With Boehringer Ingelheim BioXcellence the pharmaceutical company Boehringer Ingelheim set…

aws: BOB Phase 2

AWS, Vienna, 22 June 2012, Phase 2 for the international life science business plan competition Best of Biotech 2012…

Campus Vienna Biocenter: New play by Carl Djerassi at the Campus Vienna Biocenter Vienna

Carl Djerassi, inventor of the pill and the author of numerous novels and plays, has chosen the Campus Vienna Biocenter…

LISAvienna News

Rückblick: BIO International Convention 2012

Sorry, this entry is only available in German!

GMI: New efficient method for GWAS analysis

Published online today in Nature Genetics, Magnus Nordborg and colleagues present a faster and more efficient way to…

AUSTROMED sieht Gesundheitsversorgung gefährdet

Sorry, this entry is only available in German!

IMP: The Art of Cell Division

Scientists are joined by artists to collaborate in the EU-project “MitoSys

CeMM Principal Investigator Kaan Boztug awarded START Prize

Kaan Boztug is one of seven young scientists out of 54 applicants who have been accepted into the prestigious START…